Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Janssen Touts Positive Mid-Late Stage Data From Two Ulcerative Colitis Trials
BioSpace
Mon, 10/10/22 - 10:52 am
Tags:
JNJ, Janssen, ulcerative colitis, guselkumab, golimumab
After $100M deal, J&J links gene therapy to improved vision in early-phase trial
Fierce Biotech
Mon, 10/3/22 - 10:11 am
Tags:
JNJ, gene therapy, clinical trials, retinal disease, MeiraGTx, X-linked retinitis pigmentosa
Go or no go? GSK takes its turn with a novel anemia class
EP Vantage
Fri, 09/30/22 - 10:52 am
Tags:
FDA, GSK, Amicus Therapeutics, AstraZeneca, Novartis, Supernus, JNJ, Ipsen, Y-mAbs Therapeutics
Johnson & Johnson taps Scottish inspiration in branding its consumer spinoff
Fierce Pharma
Wed, 09/28/22 - 11:05 am
Tags:
JNJ, branding, Kenvue, consumer health, spinoffs
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda ADHD drugs
Fierce Pharma
Tue, 09/27/22 - 10:37 am
Tags:
Takeda, JNJ, Novartis, ADHD, MHRA, Concerta XL, Ritalin XL, Equasym XL
Johnson & Johnson defends bankruptcy play in appeals court, but plaintiffs call it a 'bad faith' move
Fierce Pharma
Tue, 09/20/22 - 08:33 pm
Tags:
JNJ, legal, bankruptcy
J&J opens new research hub near San Francisco
BioPharma Dive
Tue, 09/20/22 - 08:32 pm
Tags:
JNJ, San Francisco, biotech hubs, R&D
Why Novavax and Johnson & Johnson Stocks Slipped Monday
Motley Fool
Mon, 09/19/22 - 10:00 pm
Tags:
JNJ, Novavax, vaccines, Joe Biden, COVID-19
J&J settles gender discrimination and retaliation allegations involving former CEO and R&D head
Endpoints
Sun, 09/18/22 - 10:37 pm
Tags:
JNJ, legal, gender discrimination, Alex Gorsky, retaliation
J&J expands in Ireland with a $100M+ investment for contact lens manufacturing site
Endpoints
Sun, 09/18/22 - 10:20 pm
Tags:
JNJ, JNJ Vision, Ireland, contact lens
Former J&J executive settles with company in workplace discrimination lawsuit
Fierce Pharma
Thu, 09/8/22 - 04:27 pm
Tags:
JNJ, legal, gender discrimination
J&J's Biosense Launches New Mapping Catheter
Medical Devices and Diagnostics Industry
Wed, 09/7/22 - 10:20 am
Tags:
devices, Medtech, JNJ, Biosense Webster, cardiac mapping, cardiac arrhythmias
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
Tags:
FDA, Bristol Myers Squibb, deucravacitinib, Amylyx Pharmaceuticals, ALS, AMX0035, Ferring Pharmaceuticals, microbiome, RBX2660, Revance Therapeutics, Bluebird Bio, Spectrum Pharmaceuticals, JNJ, Oncopeptides
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
Clinical Trials Arena
Mon, 08/29/22 - 10:32 am
Tags:
JNJ, Janssen, clinical trials, Darzalex, Revlimid, Velcade, Multiple Myeloma
BMS, J&J's secondary stroke med falls short in phase 2 but companies see enough potential to push forward
Fierce Biotech
Sun, 08/28/22 - 10:15 pm
Tags:
JNJ, Bristol Myers Squibb, milvexian, secondary stroke, clinical trials
J&J bags first nod for multiple myeloma bispecific to complement its own CAR-T offering
Fierce Pharma
Thu, 08/25/22 - 07:43 pm
Tags:
JNJ, Europe, bispecific antibodies, Multiple Myeloma, Tecvayli, teclistamab
AbbVie, J&J's Imbruvica wins first pediatric nod, this one for chronic graft-versus-host disease
Fierce Pharma
Thu, 08/25/22 - 11:04 am
Tags:
JNJ, AbbVie, Imbruvica, graft vs host disease, pediatric, FDA
Johnson & Johnson lost to Pfizer in bidding war for Global Blood Therapeutics: Bloomberg
Fierce Pharma
Wed, 08/24/22 - 10:34 am
Tags:
Pfizer, JNJ, M&A, Global Blood Therapeutics
ESC 2022 preview – who’s got the XI factor?
EP Vantage
Tue, 08/23/22 - 10:23 am
Tags:
ESC 2022, Bristol Myers Squibb, JNJ, Bayer, Eliquis, Xarelto, bloodthinners, Lixiana, Pradaxa
After billions in legal costs, Johnson & Johnson plans to halt talc sales worldwide
Fierce Pharma
Fri, 08/12/22 - 10:46 am
Tags:
JNJ, legal, talc

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.